Sentences with phrase «percent of breast cancer»

This overproduction occurs in about 30 percent of breast cancer patients.

These mutations are linked to 5 percent to 10 percent of all breast cancer and about 15 percent of ovarian cancers, the U.S. National Cancer Institute says.

Greece has the lowest percent of breast cancer deaths and the highest cheese consumption among EU countries.

Parabens are found in 99 percent of breast cancer tissues, for example.

Western countries could avoid 25 to 30 percent of breast cancer cases if they ate less and exercised more.

About 20 percent of breast cancer cases are due to excess body fat.

Right now between 15 and 20 percent of breast cancer patients ultimately relapse, and many more experience late effects of treatment or are diagnosed with a second cancer.

But, abnormal genes make up about 10 percent of breast cancer cases, so fundraisers like this with Reese Witherspoon are critical.

Only 44 percent of breast cancer patients with a high microvessel count, low nm23 and low E-cadherin levels are alive and disease free 14 years after surgery.

Dr. Eng stressed that BRCA mutations affect few people when considering the general population; between 5 and 10 percent of breast cancer is due to mutations in the BRCA1 and BRCA2 genes.

Moreover, approximately 65 percent of breast cancer survivors are overweight or obese.

It strikes 16 percent of breast cancer patients, most of them younger than 40.

He wanted to understand why 25 percent of breast cancer patients had an identifiable, unusually fatal mutation in a gene called HER2 — and to find a drug that might target this gene.

• About 25 percent of breast cancer patients who joined support groups told researchers in a 2005 study that they attended to improve their immune systems.

Whereas only 5 to 10 percent of breast cancer patients have a mutation at one of these genes, those having it face a 40 to 85 percent chance they will develop breast cancer at some point in their lives.

About 20 percent of breast cancer patients have overexpressed growth receptors, known as Her2 + receptors, on the cancer cells, which cause uncontrolled tumor growth.

In 2010, 41 percent of breast cancer deaths occurred in the more than 19 million women who are between the ages of 65 to 84 years.

About 5 percent to 10 percent of breast cancer patients have an inherited genetic mutation that drives their cancer.

Triple - negative cancers, which affect up to 20 percent of breast cancer patients, are the most deadly and difficult to treat of all breast cancers.

Roughly 15 percent of all breast cancer patients have triple receptor - negative breast cancer, which lacks markers for a targeted therapy.

«We feel it'll be able to help kill cancer cells in 80 percent of breast cancer patients,» said Dr. Olson, who added that their antibody has the potential to help kill lung, colon, prostate and other cancer cells, too.

Doctors estimate that about 5 to 10 percent of breast cancers are linked to gene mutations passed through generations of a family.

Inflammatory breast cancer accounts for 1 to 5 percent of all breast cancers diagnosed in the United States.

The researchers found that these immune system pathways were suppressed in a large number of primary tumors — roughly 50 percent of ovarian cancers studied, 40 percent of colorectal cancers and 30 percent of breast cancers.

About 75 percent of breast cancers are ER + and grow in response to the hormone estrogen.

Triple - negative breast cancers account for 15 to 25 percent of all breast cancers and generally do not respond well to hormone therapy or standard chemotherapy.

Approximately 65 percent of all breast cancers express the estrogen receptor (ER +) and / or the progesterone receptor (PR +).

«About 40 percent of breast cancers express MSP in the tumor - so that would be the population we would try to treat with the drug.

BRCA1 mutation is inherited from a parent, and is the cause of at least ten percent of breast cancers.

Approximately 20 percent of breast cancers harbor HER2 amplification, which make these breast tumors susceptible to treatment with anti-HER2 therapies including trastuzumab and lapatinib.

«HER3 is thought to be an important mediator of resistance to the HER2 inhibitors class of anti-cancer therapies, which are used to treat HER2 - positive breast cancer representing approximately 20 percent of all breast cancers,» said principal author Eric P. Wehrenberg - Klee, MD, from Massachusetts General Hospital in Boston, Mass. «Imaging of HER3 expression may allow for better understanding of how prevalent HER3 over-expression is among HER2 positive breast cancer patients, which in turn may allow for appropriate patient selection for the addition of HER3 inhibitors currently in clinical development.»

It may explain why 77 percent of breast cancers have a normal p53 gene, and it further suggests a way that cancer cells can use both to metastasize and survive the journey to organs where they set up a new home.

The National Cancer Institute estimates no more than 10 percent of all breast cancers are due to inherited gene mutations such as BRCA1 or 2 (there are others).

These SNPs contribute to the incidence of an estimated 60 percent of all breast cancers.

The common forms of breast cancer result from the interplay of genetic as well as environmental and lifestyle factors and represent 95 percent of all breast cancers.

When tested on 335 high - risk lesions, the model correctly diagnosed 97 percent of the breast cancers as malignant and reduced the number of benign surgeries by more than 30 percent compared to existing approaches.

Approximately 70 percent of breast cancers are classified as estrogen receptor - positive — where the cancer is fueled by the hormone estrogen.

Ninety percent of breast cancers in cats are malignant — they spread quickly.

Not exact matches

Seventy five percent (75 %) of the net dollars raised through local events, including the annual Race for the Cure ®, stay in Broward, Miami - Dade and Monroe Counties to fund breast cancer screening, education and treatment initiatives.

For each year of breast - feedings, a mother reduces her risk of developing invasive breast cancer by six percent.

According to the LaLeche League International, for each year a woman breastfeeds, her risk of breast cancer decreases by 4.3 percent.

An international, collaborative study of almost 37,000 breast cancer cases published in the Annals of Oncology in October 2015 found a 20 percent reduction in risk of developing hormone - receptor negative breast cancer for women who breastfed.

But a larger group of studies over the past ten years has proved that women who breastfeed their children past the age of two years actually reduce their chances of contracting pre-menopausal breast cancer by 30 percent.

A study of nearly 3,000 women conducted by researchers at the University of Buffalo in New York found women who experienced morning sickness during pregnancy were 30 percent less likely to have breast cancer later in life.

According to the recent study, which will be published next month in the print version of the American Journal of Clinical Nutrition, breastfeeding can cut the risk of breast cancer by up to 91 percent.

State Attorney General Eric Schneiderman has reached a settlement with what he termed a «shell» breast cancer charity that was raising lots of money but keeping 92 percent of the proceeds rather than administering medical care.

James said that while there is a 99 percent survival rate if breast cancer is detected early, black women are 42 percent more likely to die from breast cancer than their white counterparts and Hispanic women have significantly higher rates of being diagnosed with advanced breast cancer than either white or black women.

When examining reproductive cancers, the authors noted that while patients with infertility were 44 percent more likely to die of breast cancer, infertility was not associated with an increased risk of ovarian cancer or death from ovarian or endometrial cancers.

The authors report that the best estimate of the reduction in mortality from breast cancer due to annual screening for women overall is about 19 percent.

News of a 26 percent increase in breast cancers and a 41 percent increase in strokes caused confusion and alarm.